Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4945 - 4952 of 11617 results
Supreme Court Eyes Hospital Giant's FCA Case
February 25, 2019| News
ICYMI – Overview of California Consumer Privacy Act Webinar
February 22, 2019| Blog| Viewpoint
The Thrill of a Visa, the Agony of Denial: Visa Challenges for the Esports Athlete
February 22, 2019| Advisory| Viewpoint
Device Modernization Series: FDA’s Changes to the 510(k) Program
February 21, 2019| Blog| Viewpoint
CMS Continues to Combat the Opioid Epidemic
February 21, 2019| Blog| Viewpoint
Independent Laboratory Settles Medical Necessity Allegations
February 20, 2019| Blog| Viewpoint
How to Diligence a Solar Development Pipeline (Part 1 of 4)
February 20, 2019| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.